NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,279.78 mln
Float119 mln
Earnings Date05/05/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.41
Borderline
1-Year Forecast
20.57
Exceptional upside
Relative Strength
46
/ 100
Slightly lagging
Debt / Equity
0.36
Low leverage
ROE
-29.87
Deeply negative
Business Description
Adaptive Biotechnologies, founded in 2009 and based in Seattle, Washington, uses advanced immune system analysis to help diagnose and treat a range of diseases. The company's core platform reads and interprets data from the immune system using proprietary biology and machine learning tools. Its flagship product, the clonoSEQ test, helps doctors detect and track tiny amounts of remaining cancer cells in patients during and after treatment. The company serves researchers, clinicians, and drug developers across the healthcare industry.
